|
|
(64 intermediate revisions by the same user not shown) |
Line 1: |
Line 1: |
| Understanding of '''haematopathology''' is important in [[anatomical pathology]], as '''haematologic malignancies''' are often in the (clinical) differential diagnosis and may mimic ''[[small blue round cell tumours]]'' or ''[[breast|lobular breast carcinoma]]''. | | Understanding of '''haematopathology''' is important in [[anatomical pathology]], as '''haematologic malignancies''' are often in the (clinical) differential diagnosis and may mimic ''[[small blue round cell tumours]]'' or ''[[breast|lobular breast carcinoma]]''. |
|
| |
|
| ==Bone marrow==
| | The lymph node is discussed below; however, details are covered in the ''[[lymph node]]'' article and ''[[lymph node pathology]]'' article. |
| {{main|Bone}}
| |
| Bone marrows are important for understanding haematopathology. They are dealt with in the ''[[bone]]'' article.
| |
|
| |
|
| ==Normal lymph node== | | =Bone marrow= |
| ===Normal (clinical)===
| | {{main|Bone marrow}} |
| *Round.
| | Bone marrows are important for understanding haematopathology. They are dealt with in the ''[[bone marrow|bone]]'' article. |
| *"Soft".
| |
| *Mobile.
| |
|
| |
|
| ===Pathologic (clinical) - associations=== | | =Normal lymph node= |
| *Rubbery = suggestive of lymphoma.
| | {{main|Lymph node}} |
| *Fixed (immobile) = suggestive of cancer.
| | {{main|Lymph node pathology}} |
| *Tender (hurts when ya touch it) = suggestive of infection.
| |
| | |
| ===Radiologic & clinical===
| |
| *Elongated = may be cancer.
| |
| *"Large" = could be cancer or infection.
| |
| | |
| ===Malignant - statistical associations===
| |
| Nodes with metstases tend to be:
| |
| *Hard.
| |
| *Ellipical (as opposed to circular) on section.
| |
| *"Large".
| |
| *May be immobile (fixed to a surrounding structure).
| |
| | |
| Note:
| |
| *"Large" depends on the location in the body.
| |
| | |
| ===Gross pathologic exam===
| |
| Normal:
| |
| *Firm (relative to adipose tissue).
| |
| *Glissening surface when cut.
| |
| | |
| Pathologic:
| |
| *White lesions, espically irregular = suggestive of carcinoma.
| |
| *white, glissening, with lobulated surface - "fish flesh" = suggestive of lymphoma.
| |
|
| |
|
| ===Microscopic=== | | ===Microscopic=== |
| {{main|Lymph node}}
| |
| The microscopic lymph node architecture in described the ''[[lymph node]]'' article, along with B cell maturation and lymph node cell types. | | The microscopic lymph node architecture in described the ''[[lymph node]]'' article, along with B cell maturation and lymph node cell types. |
|
| |
|
Line 58: |
Line 29: |
| **Plasma cells. | | **Plasma cells. |
|
| |
|
| ==Heparin-induced thrombocytopenia== | | =Haematologic neoplasia= |
| *Thrombocytopenia due to heparin.<ref>[http://emedicine.medscape.com/article/1357846-overview http://emedicine.medscape.com/article/1357846-overview]</ref>
| | Historically, haematologic neoplasias were split into leukemia (disease of the bone marrow & blood) and lymphoma (disease in discrete masses -- usually lymph nodes). In the modern day, this distinction has blurred. |
|
| |
|
| Classification:
| | ==Myelodysplastic syndrome== |
| *Type 1 - in first two days of exposure - considered non-immune and considered not to be serious.
| | {{Main|Myelodysplastic syndrome}} |
| *Type 2 - in the first 4-10 days - considered serious.
| | At first approximation, these can be thought of as "pre-leukemia/lymphoma". |
|
| |
|
| Diagnosis (simplified):
| | ==Leukemia== |
| *50% decline in platelets - within 4-10 days of starting heparin.
| | {{Main|Leukemia}} |
| *HIT assay - several exist.<ref>[http://emedicine.medscape.com/article/1357846-diagnosis http://emedicine.medscape.com/article/1357846-diagnosis]</ref>
| | These predominantly have blood/bone marrow involvement. |
|
| |
|
| ==Lymphoma classification== | | ==Lymphoma== |
| Lymphomas can be divided into:
| | {{main|Lymphoma}} |
| *Hodgkin's lymphoma.
| | These form masses. They typically arise from lymph nodes or aggregates of lymphocytes. |
| *Non-Hodgkin's lymphoma (NHL).
| |
|
| |
|
| Other categorizations:
| | ==Plasma cell lesions== |
| *T cell lymphomas (rare).
| | {{Main|Plasma cell neoplasms}} |
| *B cell lymphomas (more common).
| |
|
| |
|
| Two most common NHLs:
| | ==Myeloproliferative neoplasms== |
| *Follicular lymphoma (FL).
| | {{main|Myeloproliferative neoplasms}} |
| *Diffuse large B-cell lymphoma (DLBCL).
| | This subset of haematopathology includes, among others, polycythemia vera. Historically, these were not classified as neoplasias. |
|
| |
|
| ===Lymphoma as a med student=== | | =Specific diagnoses= |
| *Acute lymphoid leukemia (ALL) - predominantly in '''smALL''' people, i.e. children.
| | ==Hemophagocytic syndrome== |
| *Acute myeloid leukemia (AML).
| | {{main|Hemophagocytic syndrome}} |
| *Chronic myeloid leukemia (CML).
| | ===General=== |
| *Chronic lymphoid leukemia (CLL) - relatively good prognosis.
| | *Rare. |
| | |
| ===Histology===
| |
| *Lymphomas = cells look discohesive, may be difficult to differentiate from poor differentiated carcinoma.
| |
| *Auer rods = Acute myeloid leukemia.
| |
| **Granular cytoplasmic rod (0.5-1 x4-6 micrometres).
| |
| *Reed-Sternberg cells = Hodgkin's lymphoma.
| |
| **Large cell - very large nucleus.
| |
| ***Classically binucleated.
| |
| *Russell bodies = Plasmacytoma (+others).
| |
| **Eosinophilic, large, homogenous immunoglobulin-containing inclusions.<ref name=pmid3979421>{{cite journal |author=Alanen A, Pira U, Lassila O, Roth J, Franklin RM |title=Mott cells are plasma cells defective in immunoglobulin secretion |journal=Eur. J. Immunol. |volume=15 |issue=3 |pages=235–42 |year=1985 |month=March |pmid=3979421 |doi= |url=}}</ref>
| |
| ***''Mott cell'' is a cell that contains Russell bodies.<ref name=pmid3979421/>
| |
| | |
| ===IHC===
| |
| *CD45+.
| |
| **AKA ''common lymphocyte antigen''.
| |
| **Useful to differentiate from carcinomas (e.g. small cell carcinoma).
| |
| *CD3 -- T cell marker (all T cells).
| |
| **CD4 -- subset of T cells.
| |
| **CD8 -- subset of T cells.
| |
| *CD20 -- B cell marker.
| |
| **CD19 -- B cell marker - used for flow cytometry.
| |
| *CD10 -- follicular cell ???
| |
| *CD30 -- Hodgkin's lymphoma (most sensitive).
| |
| | |
| ==Hodgkin's lymphoma== | |
| *Abbreviated ''HL''.
| |
| | |
| ===Clinical===
| |
| Sx:<ref name=wmsp_p567>WMSP P.567.</ref>
| |
| *Fever, night sweats, weight loss.
| |
| *Infections (due to immune dysfunction).
| |
| | |
| Diagnosis:
| |
| *HL cannot be diagnosed with standard flow cytometry (FC) - but has been diagnosed with specialized FC.<ref>{{cite journal |author=Fromm JR, Thomas A, Wood BL |title=Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity |journal=Am. J. Clin. Pathol. |volume=131 |issue=3 |pages=322–32 |year=2009 |month=March |pmid=19228638 |doi=10.1309/AJCPW3UN9DYLDSPB |url=}}</ref>
| |
| ===Histology===
| |
| *Reed-Sternberg cell (by definition).
| |
| **Large binucleated cell.
| |
| **Macronucleolus - approximately the size of a RBC.
| |
| | |
| ===HL subtypes===
| |
| Types:<ref name=wmsp_p567/>
| |
| *Classical HL (CHL) - ~95% of HL.
| |
| *Nodular lymphocyte-predominant HL (NLPHL) - ~5% of HL.
| |
| | |
| | |
| ===Classical HL===
| |
| There are four CHL subtypes:<ref name=wmsp_p567/>
| |
| #Nodular sclerosis CHL - ~70% of CHL.
| |
| #*Mixed cellular background - T cell, plasma cells, eosinophils, neutrophils and histiocytes.
| |
| #*Nodular sclerosing fibrosis - thick strands fibrosis.
| |
| #Mixed cellularity CHL - ~20-25% of CHL.
| |
| #*Like nodular sclerosis - but no fibrosis.
| |
| #Lymphocyte-rich CHL - rare.
| |
| #*T lymphocytes only (no mix of cells).
| |
| #Lymphocyte-depleted CHL - rare.
| |
| #*Assoc. with HIV infection.
| |
| | |
| Memory device:
| |
| *The subtypes prevalence is in reverse alphabetical order.
| |
| | |
| ===Nodular lymphocyte-predominant HL=== | |
| *AKA ''lympho-histiocytic variant''. | |
|
| |
|
| | ===Microscopic=== |
| Features: | | Features: |
| *The diagnostic cells in this variant: relatively small, lobulated nucleus, small nucleoli. | | *Macrophages eat RBCs, WBCs. |
|
| |
|
| Image:
| | ==Heparin-induced thrombocytopenia== |
| *[http://webpathology.com/image.asp?case=388&n=16 Popcorn cell (webpathology.com)]. | | *Thrombocytopenia due to heparin.<ref name=emed_hit>URL: [http://emedicine.medscape.com/article/1357846-overview http://emedicine.medscape.com/article/1357846-overview]. Accessed on: 17 May 2011.</ref> |
|
| |
|
| ===IHC===
| | Classification: |
| Abbreviated panel - see WMSP for details:<ref>WMSP P.568.</ref>
| | *Type 1 - in first two days of exposure - considered non-immune and considered not to be serious. |
| *CD30 Reed-Sternberg cells (RSCs) +ve ~98% | | *Type 2 - in the first 4-10 days - considered serious. |
| *CD15 Reed-Sternberg cells +ve ~80%, stains neutrophils.
| |
| *CD45 '''often negative''' in RSCs. | |
| *CD20 may stain RSCs.
| |
| *PAX5 +ve.<ref>APBR P.683.</ref>
| |
|
| |
|
| Additional - for completeness:
| | Diagnosis (simplified): |
| *CD3 (T lymphocytes) | | *50% decline in platelets - within 4-10 days of starting heparin. |
| | *HIT assay - several exist.<ref name=emed_hit>URL: [http://emedicine.medscape.com/article/1357846-overview http://emedicine.medscape.com/article/1357846-overview]. Accessed on: 17 May 2011.</ref> |
|
| |
|
| NLPHL IHC '''differs''' from the classical HL:<ref>APBR P.683.</ref>
| | ==Disseminated intravascular coagulation== |
| *LCA +ve.
| | *Commonly abbreviated ''DIC''. |
| *CD20 +ve.
| | ===General=== |
| *CD10 +ve.
| | *Usually associated with sepsis or septic shock.<ref>URL: [http://emedicine.medscape.com/article/779097-overview http://emedicine.medscape.com/article/779097-overview]. Accessed on: 23 October 2010.</ref> |
| *Bcl-6 +ve.
| |
| *EMA +ve.
| |
| *CD30 -ve
| |
| *CD15 -ve.
| |
|
| |
|
| ==Follicular lymphoma==
| | Clinical: |
| *A common type of lymphoma. | | *Schistocytes (red blood cell fragmentation). |
|
| |
|
| ===Microscopic=== | | ===Gross=== |
| *Abundant abnormal lymphoid follicles.
| | Features:<ref>{{Ref HospAuto|209}}</ref> |
| | | *Pleural petechial haemorrhages. |
| ==Diffuse large B-cell lymphoma==
| |
| *Abbreviated ''DLBCL''. | |
|
| |
|
| ===Microscopic=== | | ===Microscopic=== |
| Features:<ref>PBOD P.676. (???)</ref> | | Features:<ref name=Ref_PBoD8_670>{{Ref PBoD8|670}}</ref> |
| *Large cells -- 4-5 times the diameter of a small lymphocytes. | | *Microvascular occlusion. |
| *Typically have marked cell-to-cell variation in size and shape.
| |
| *Cytoplasm usu. basophilic and moderate in abundance.
| |
| *+/-Prominent nucleoli, may be peripheral and/or multiple.
| |
|
| |
|
| Notes: | | Notes: |
| *Large bizarre cells can occasionally mimic Reed-Sternberg cells, seen in Hodgkin lymphoma. | | *Microvascular occlusion is also seen in [[thrombotic microangiopathies]]. |
| | |
| ==Burkitt's lymphoma==
| |
| ===General===
| |
| *Abbreviated ''BL''.
| |
| *Extremely high proliferative rate & rate of apoptosis.
| |
| | |
| ===Subtypes===
| |
| *Three subtypes recognized:<ref name=pmid12610094>{{cite journal |author=Bellan C, Lazzi S, De Falco G, Nyongo A, Giordano A, Leoncini L |title=Burkitt's lymphoma: new insights into molecular pathogenesis |journal=J. Clin. Pathol. |volume=56 |issue=3 |pages=188–92 |year=2003 |month=March |pmid=12610094 |pmc=1769902 |doi= |url=http://jcp.bmj.com/cgi/pmidlookup?view=long&pmid=12610094}}</ref>
| |
| #Endemic:
| |
| #*Found in Africa.
| |
| #*EBV (Epstein-Barr virus) associated.<ref name=pmid12610094/>
| |
| #Non-endemic:
| |
| #*Typical of the BL seen in the western world; EBV negative.
| |
| #Immunodeficiency associated:
| |
| #*Associated with HIV infection.
| |
| | |
| ===Pathophysiology===
| |
| *Origin cell: germinal centre B cells (favoured) vs. memory B cells.<ref name=pmid12610094/>
| |
| *Common translocation t(8;14).<ref name=pmid12610094/>
| |
| | |
| ===Cytologic definition===
| |
| *t(8;14) (q24;q32) translocation + a few variants or c-myc rearrangement.<ref name=pmid12610094/>
| |
| | |
| ===Histology===
| |
| *"Starry-sky pattern".
| |
| **The ''stars'' in the pattern are: tingible-bodies laden macrophages.
| |
| ***''[[Tingible-bodies macrophages]]'' = macrophages containing dead body of apoptotic tumor cells.
| |
| *Tumour cells:<ref name=pmid12610094/>
| |
| **Medium size.
| |
| **Round nuclei.
| |
| **Multiple nucleoli.
| |
| **Relatively abundant cytoplasm.
| |
| | |
| Image: [http://en.wikipedia.org/wiki/File:Burkitt_lymphoma,_H%26E.jpg Starry-sky pattern - Ed Uthman (www.wikipedia.org)].
| |
| | |
| ==Plasmacytoma==
| |
| ===General===
| |
| *Malignancy derived from the plasma cells.
| |
| *Histologic component of ''multiple myeloma''; to diagnose multiple myeloma other (non-pathology) criteria are needed.
| |
| | |
| ===Microscopic===
| |
| *Cells with "clock face" nuclei.
| |
| *Russell bodies:
| |
| **Eosinophilic, large (10-15 micrometres), homogenous immunoglobulin-containing inclusions.
| |
| ***Images: [http://www.healthsystem.virginia.edu/internet/hematology/hessimages/russell-bodies-website-arrow.jpg Russel bodies (healthsystem.virginia.edu)], [http://www.pathguy.com/lectures/russ2.jpg Russel bodies (pathguy.com)] - several in one cell.
| |
| *Dutcher bodies - intranuclear crystalline rods.
| |
| *Prominent ''perinuclear hof'' - cresent shaped lucency at the nuclear membrane (due to large Golgi apparatus).
| |
| | |
| Images: [http://ashimagebank.hematologylibrary.org/cgi/content/full/2004/0126/100984 http://ashimagebank.hematologylibrary.org/cgi/content/full/2004/0126/100984].
| |
| | |
| DDx:
| |
| *Neuroendocrine carcinoma - nucleus often has a plasmacytoid (plasma cell) look.
| |
| | |
| ==Acute myeloid leukemia==
| |
| ===General===
| |
| *May afflicits young adult.
| |
| *Males>females.
| |
| | |
| ===Complications===
| |
| *Chloroma - soft tissue mass.
| |
| *Leukostasis.
| |
| **Occurs - lungs and brain.<ref>AML. Harrison's 16th Ed.</ref>
| |
| *Hyperviscosity syndrome.
| |
| *Spontaneous bleeding with low platelet counts.
| |
| | |
| ===Classification===
| |
| There are two classifications:
| |
| #FAB (French-American-British) - based on histologic appearance/maturation.
| |
| #WHO classification.
| |
| | |
| ===Histology===
| |
| *Auer rods - not required to diagnose.<ref>AG. 8 July, 2009.</ref>
| |
| **Cytoplasmic granular rods in blast cells.
| |
| ***Dimensions: approx. 0.5-1 x 4-6 micrometres.
| |
| **Images: [http://en.wikipedia.org/wiki/File:Auer_rods.PNG Auer rods (WP)], [http://www.healthsystem.virginia.edu/internet/hematology/HessImages/Acute-myelogenous-leukemia-M4-100x-Auer-rods-website-arrow.jpg Auer rods (virginia.edu)].
| |
| | |
|
| |
|
| ==Table of B-cell lymphoma== | | =Cytometry - population cell marker quantification= |
| {| class="wikitable" | | {{main|Cytometry}} |
| ! Name
| |
| ! Location
| |
| ! Size of cells
| |
| ! IHC
| |
| ! Translocations
| |
| ! Clinical
| |
| ! Other
| |
| |-
| |
| | Follicular lymphoma
| |
| | Follicle
| |
| | Small, centrocytes, centroblasts
| |
| | CD10, bcl-6
| |
| | t(14,18)
| |
| | Clinical ?
| |
| | Other ?
| |
| |-
| |
| | Burkitt's lymphoma
| |
| | Follicle
| |
| | Large cells
| |
| | CD10, bcl-6
| |
| | t(8;14) (q24;q32)
| |
| | Rapid growth
| |
| | "Starry sky"
| |
| |-
| |
| | Diffuse large B cell lymphoma
| |
| | Follicle (?)
| |
| | Large 4-5X of lymphocyte
| |
| | MIB-1 >40%
| |
| | none/like follicular l.
| |
| | Poor prognosis
| |
| | Common among lymphomas
| |
| |-
| |
| | Name
| |
| | Location
| |
| | Size of cells
| |
| | IHC
| |
| | Translocations
| |
| | Clinical
| |
| | Other
| |
| |}
| |
|
| |
|
| ==Population cell marker quantification== | | ===Two techniques=== |
| Two techniques: | | #[[Flow cytometry]]. |
| *Flow cytometry.
| | #Laser scanning cytometry (LSC). |
| *Laser scanning cytometry (LSC).
| |
|
| |
|
| Common markers: | | ===Common markers=== |
| *CD3, CD4, CD8, CD5, CD7. | | *CD3, CD4, CD8, [[CD5]], CD7. |
| *CD19, CD20, FMC7. | | *CD19, [[CD20]], FMC7. |
| *Kappa, lambda. | | *Kappa, lambda. |
|
| |
|
| Normal: | | ===Normal=== |
| *T-cells to B-cells usually 1:1. | | *T-cells to B-cells usually 1:1. |
| *In reactive nodes T-cell predominate. | | *In reactive nodes T-cells predominate. |
| *Normal thymic tissue has cells that are positive for both CD4 and CD8. | | *Normal thymic tissue has cells that are positive for both CD4 and CD8. |
| *Kappa (k) and lambda (l) are not expressed by the same cell. | | *Kappa (k) and lambda (l) are not expressed by the same cell. |
Line 333: |
Line 112: |
|
| |
|
| GS guidelines - non-malignant is:<ref>GS. LSC Procedure. March 11, 2010.</ref> | | GS guidelines - non-malignant is:<ref>GS. LSC Procedure. March 11, 2010.</ref> |
| *CD19 ~= CD20 | | *CD19 ~= CD20. |
| *CD5 = CD3 | | *CD5 = CD3. |
| *CD2 > CD3 and CD5 | | *CD2 > CD3 and CD5. |
| *CD4 + CD8 ~= CD3 | | *CD4 + CD8 ~= CD3. |
| *CD7 = the smalest number of T-cell | | *CD7 = the smallest number of T-cell. |
|
| |
|
| Abnormal: | | ===Abnormal=== |
| *CD4>CD8 predominance classically seen in:
| | See ''[[cytometry]]''. |
| **Sarcoidosis.
| |
| **Hodgkin's lymphoma.
| |
| *T cell lymphoma - loss of one of the T-cell markers (CD2, CD3, CD5 or CD7).
| |
|
| |
|
| ===Sample report=== | | =Abnormal sign out= |
| B-Cell Associated Markers
| | <pre> |
| *CD10.
| | Lymph Node, Right Posterior Triangle of Neck, Excision: |
| **Germinal centre marker.
| | - Lymphoid tissue with abnormal architecture, predominantly small cells. |
| **+ve in: follicular l., Burkitt l., precursor lymphoblastic leukemia.
| | - Case will be sent to hematopathology for opinion. |
| *CD19.
| | </pre> |
| **B cell marker.
| |
| **Should be ~=CD20.
| |
| *CD20.
| |
| **B cell marker.
| |
| **Should be ~=CD20.
| |
| *CD23.
| |
| **+ve in CLL/SLL.
| |
| *FMC7
| |
| **B cell marker.
| |
| *Kappa+CD19/20+.
| |
| **B cell clonality.
| |
| *Lambda+CD19/20+
| |
| **B cell clonality.
| |
|
| |
| T-Cell Associated Markers
| |
| *CD3.
| |
| **CD3 ~= CD4 + CD8.
| |
| **Usually: CD2 > CD3 > CD7.
| |
| *CD5.
| |
| **Usually: CD2 > CD5 > CD7.
| |
| *CD4.
| |
| **CD3 ~= CD4 + CD8.
| |
| *CD8.
| |
| **CD3 ~= CD4 + CD8.
| |
| *CD7.
| |
| **Usually least prevalent T cell marker; < CD2, < CD3, < CD5.
| |
| *CD2.
| |
| **Usually most prevalent T cell marker; > CD3, > CD5, > CD7.
| |
|
| |
| NK-Cell Associated Markers
| |
| *CD56.
| |
| *CD16.
| |
|
| |
| Miscellaneous Markers
| |
| *CD11c.
| |
| *CD14.
| |
|
| |
|
| ==See also==
| | =See also= |
| *[[Stomach]]. | | *[[Stomach]]. |
| *[[Lymph nodes]]. | | *[[Lymph nodes]]. |
|
| |
|
| ==References==
| | =References= |
| {{reflist|2}} | | {{reflist|2}} |
|
| |
|
| [[Category:Haematopathology]] | | [[Category:Haematopathology]] |